Vicagrel
Based on 1 publication(s) in Google Scholar
Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.92%
- CAS No.: 1314081-53-2
- 화학식: C18H18ClNO4S
- 분자량:379.86
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
HY-15284A
Prasugrel hydrochloride
-
HY-19638A
Cangrelor tetrasodium
-
HY-108648
2-MeS-ADP trisodium
-
HY-13831
BPTU
-
HY-15283
Clopidogrel
-
HY-10064
Ticagrelor
-
HY-15876
Clopidogrel thiolactone
-
HY-15799
AZD1283
-
HY-B0606
Diquafosol tetrasodium
-
HY-111557
YM-254890
-
HY-18775
N6-(4-Hydroxybenzyl)adenosine
-
HY-17459
Clopidogrel hydrogen sulfate
Publications Citing Use of MedChemExpress (MCE) Vicagrel
MoreAll P2Y Receptor Isoforms
More
Biological Activity
Vicagrel (compound 9a) (20 μM, 30 min) activates production of the active metabolite from in vitro rat liver microsomal[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Vicagrel (oral, 1.14 mg/mL, 0-24 h) has giood preliminary pharmacokinetic with high bioavailability and low clinically effective dose[1].
Vicagrel (oral, 5 g/kg, single, for 14 days) has low dose-related toxicity in mouse[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar rats[1]
(200−250 g) -
Dosage:3 mg/kg
-
Administration:oral
-
Result:Inhibitied platelet aggregation by ADP-induced in rats.
-
Animal Model:SD male rats[1]
-
Dosage:1.14 mg/mL
-
Administration:oral, 0-24 h
-
Result:Could be readily converted into clopidogrel thiolactone and had high bioavailability.
-
Animal Model:Mice[1]
-
Dosage:5 g/kg
-
Administration:oral, single, for 14 days
-
Result:Had very low acute toxicity.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1314081-53-2
-
Appearance Solid
-
분자량 379.86
-
화학식 C18H18ClNO4S
-
Color White to off-white
-
SMILES
O=C(OC)[C@@H](N1CCC2=C(C=C(OC(C)=O)S2)C1)C3=CC=CC=C3Cl
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Chem Biol Interact
Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions. [Abstract]2022 Jan 25:352:109775. PMID: 34910929
용액&용해도
DMSO : 250 mg/mL (658.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (5.48 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6325 mL | 13.1627 mL | 26.3255 mL | 65.8137 mL |
| 5 mM | 0.5265 mL | 2.6325 mL | 5.2651 mL | 13.1627 mL | |
| 10 mM | 0.2633 mL | 1.3163 mL | 2.6325 mL | 6.5814 mL | |
| 15 mM | 0.1755 mL | 0.8775 mL | 1.7550 mL | 4.3876 mL | |
| 20 mM | 0.1316 mL | 0.6581 mL | 1.3163 mL | 3.2907 mL | |
| 25 mM | 0.1053 mL | 0.5265 mL | 1.0530 mL | 2.6325 mL | |
| 30 mM | 0.0878 mL | 0.4388 mL | 0.8775 mL | 2.1938 mL | |
| 40 mM | 0.0658 mL | 0.3291 mL | 0.6581 mL | 1.6453 mL | |
| 50 mM | 0.0527 mL | 0.2633 mL | 0.5265 mL | 1.3163 mL | |
| 60 mM | 0.0439 mL | 0.2194 mL | 0.4388 mL | 1.0969 mL | |
| 80 mM | 0.0329 mL | 0.1645 mL | 0.3291 mL | 0.8227 mL | |
| 100 mM | 0.0263 mL | 0.1316 mL | 0.2633 mL | 0.6581 mL |
Vicagrel Related Classifications
HY-118284 Related Classifications
Powered by Bioz